Why Is Asia-Pacific the Fastest-Growing Region in the CGRP Antagonist Market?
North America and Europe remain the largest markets for CGRP antagonists, but the growth frontier has shifted east. Asia-Pacific is forecast to be the fastest-growing region, driven by rising migraine awareness, improving specialty neurology access, and increasing healthcare expenditure in China, Japan, South Korea, and India . This trajectory is reshaping competitive dynamics across the global...
Yogita Bankar
2026-10-22 09:26:38